Hydroxychloroquine now approved as a preventative treatment for COVID-19 (Update)by Rick Johnson
Feb 23, 2021
LOS ANGELES, CA: As the COVID-19 pandemic explodes in the New York region and across California, the Malaria drug Hydroxychloroquine (HCQ) stood to play a major role as both a treatment for and as a prophylactic to prevent coronavirus infection. When it was used in combination with Azithromycin, it did show great promise in infected patients.
There are numerous accounts of the most seriously ill patients making a full recovery. Of countries that relied on
From Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context:
Treatments & Efficacy
The three most commonly prescribed treatments amongst COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine
Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK and 7% in Japan
Hydroxychloroquine was overall chosen as the most effective therapy amongst COVID-19 treaters from a list of 15 options (37% of COVID-19 treaters)
* 75% in Spain, 53% Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S. and 13% in the U.K. ...
Conclusion
Although this is a retrospective analysis, results suggest that early diagnosis, early isolation, and early treatment of COVID-19 patients, with at least 3 days of HCQ-AZ lead to a significantly better clinical outcome and a faster viral load reduction than other treatments. ...
More at
https://www.commdiginews.com/politics-2/hydroxychloroquine-approved-preventative-treatment-covid-19-128426/I know, we're all shocked.
